RecruitingNCT07698977

Inhibition of Myopia Progression With Optical Devices


Sponsor

Semmelweis University

Enrollment

50 participants

Start Date

Jun 2, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to determine whether optical devices designed to slow myopia progression and/or environmental factors can prevent myopia progression in the pediatric and adolescent myopic population. The study aims to answer the following questions: 1. How does myopia progression change with age while wearing myopia progression control glasses? 2. How does myopia progression change while wearing myopia progression-control glasses when environmental factors, such as time spent outdoors and place of residence, are taken into account? 3. How does myopia progression change at different ages while wearing myopia progression control glasses given a family history of myopia? This will be a self-controlled observational study. Participants who are myopic after cycloplegic refraction will be prescribed DIMS glasses. DIMS stands for "defocus incorporated multiple segments," a specialized optical technology used in spectacle lenses to slow nearsightedness progression in children. Patients will keep a diary of their subjective symptoms and environmental factors, e.g., time spent outdoors and screen time. Patients will visit the clinic once every six months for checkups and the following tests: * Best corrected visual acuity test * Stereopsis * Automatic refractometry * Bulbar axial length measurement In a follow-up study, researchers will compare myopia progression with environmental and baseline factors to learn about the long-term effects of DIMS lenses on myopia progression.


Eligibility

Min Age: 6 YearsMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called DIMS (Defocus Incorporated Multiple Segments) lenses and a medical device called Wearing myopia-control D.I.M.S. glasses while awake for people with myopia, myopia progression, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEWearing myopia-control D.I.M.S. glasses while awake

DIMS (Defocus Incorporated Multiple Segments) lenses wearing while awake

DEVICEDIMS (Defocus Incorporated Multiple Segments) lenses

D.I.M.S. lenses are worn like normal glasses to correct myopia and, beyond that, their special design is intended to slow myopia progression via defocus lenslets. There is targeted myopic defocus produced by the mid-peripheral lenslets with positive power to inhibit eye length growth.


Locations(1)

Semmelweis University Ophthalmology Department

Budapest, Hungary

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07698977


Related Trials